舒畅

美国斯坦福大学医学院血管外科博士后,一级主任医师、教授、博导。

现任血管外科中心主任,血管中心二病区主任。
是国家重点临床专科学术带头人,国家卫计委首批外周血管疾病介入诊疗培训基地学科带头人,美国斯坦福大学、耶鲁大学、纽约大学、圣克莱尔医院及香港大学、新加坡国立大学医学院客座教授。国际血管联盟前任副主席,国际静脉联盟中国分会候任会长,外周动脉疾病泛大西洋协作组(TASC)标准委员会委员,美国血管外科学会(SVS)国际委员,国家心血管病专家委员会委员,国家心血管病专家委员会血管外科专业委员会主任委员,中华医学会外科学分会委员和血管外科学组委员,中国医师协会腔内血管学专业委员会、中国医促会血管外科分会、中国医师协会外科分会血管外科专业委员会、中华医学会血管外科及生物工程分会、中国研究型医院学会血管医学专业委员会、中国医疗器械行业协会血管器械分会等6家全国学会副主任委员等。
擅长主动脉疾病、外周动脉疾病的诊治,主刀主动脉疾病介入微创手术两千余台,率先在国内开展一系列前沿技术,是第一位在国际上报道“烟囱”技术微创治疗主动脉弓部夹层的中国专家。

主持国家、省部级科研基金等多项,在国内外期刊发表论文100余篇,其中SCI收录30余篇。
2007年获 “中国医师奖”,2008年被评为“全国卫生系统先进个人”,2011年被美国中华医学基金会(CMB)评为“杰出教授”;2012年被评为中南大学首届“湘雅名医”,入选首批全国名医百强榜。
受邀前往三大洲9个国家进行主动脉疾病介入微创手术示范50余台。作为唯一的中国血管外科专家,2015、2016连续两年应邀在南美CICE大会上向全球同行直播主动脉腔内手术,2016年应邀在美国C3会议上直播主动脉腔内手术。为印尼、阿根廷、巴西、菲律宾、希腊培训血管外科专科医师(5个国家9批次共计50名高级进修学员来华接受血管外科专科培训)。
受邀赴30多个国家和地区作主动脉疾病诊治相关的学术报告50场以上。连续4年受邀出席美国外科学院年会、连续5年作为Faculty Member受邀出席美国Veith Meeting,并作专题报告。作为大会共同主席,率中国血管外科代表团在英国皇家医学院心血管峰会上首次开辟中西方对话专场。作为唯一的中国专家,在第24届欧洲血管外科年会开幕式全体大会上介绍主动脉疾病腔内治疗的中国经验。代表中国,参与TASC国际外周血管疾病诊治指南的制定。

Postdoctoral Fellow in Vascular Surgery at Stanford University School of Medicine, USA; First-Class Chief Physician, Professor, and Doctoral Supervisor.

Currently serving as the Director of the Vascular Surgery Center and Head of the Second Ward of the Vascular Center. A leading academic figure in a national key clinical specialty and the discipline leader of the first batch of peripheral vascular disease interventional diagnosis and treatment training bases under the National Health Commission. Guest Professor at Stanford University, Yale University, New York University, St. Clare Hospital in the USA, as well as the University of Hong Kong and the National University of Singapore School of Medicine. Former Vice President of the International Union of Angiology, President-Elect of the Chinese Chapter of the International Union of Phlebology, Member of the TransAtlantic Inter-Society Consensus (TASC) Standards Committee, International Member of the Society for Vascular Surgery (SVS), Member of the National Cardiovascular Disease Expert Committee, and Chairman of the Vascular Surgery Committee of the National Cardiovascular Disease Expert Committee. Also serves as a member of the Surgery Branch and Vascular Surgery Group of the Chinese Medical Association, and holds vice-chairman positions in six national societies, including the Endovascular Committee of the Chinese Medical Doctor Association, the Vascular Surgery Branch of the China International Exchange and Promotive Association for Medical and Health Care, and the Vascular Surgery Committee of the Chinese Medical Doctor Association.

Specializes in the diagnosis and treatment of aortic and peripheral arterial diseases, having performed over 2,000 minimally invasive interventional surgeries for aortic diseases. Pioneered a series of advanced techniques in China and was the first Chinese expert to internationally report the "chimney" technique for minimally invasive treatment of aortic arch dissection.

Has led multiple national and provincial-level research funds and published over 100 papers in domestic and international journals, including more than 30 SCI-indexed articles.

Awarded the "Chinese Physician Award" in 2007, recognized as a "National Advanced Individual in the Health System" in 2008, and honored as an "Outstanding Professor" by the China Medical Board (CMB) in 2011. In 2012, was named among the first "Xiangya Distinguished Physicians" at Central South University and included in the inaugural list of China's Top 100 Physicians.

Invited to perform over 50 minimally invasive interventional surgeries for aortic diseases across nine countries on three continents. As the only Chinese vascular surgery expert, was invited to demonstrate live aortic endovascular surgeries at the CICE conference in South America in 2015 and 2016, and at the C3 conference in the USA in 2016. Has trained vascular surgery specialists from Indonesia, Argentina, Brazil, the Philippines, and Greece, with a total of 50 advanced trainees from these countries coming to China for specialized training.

Invited to deliver over 50 academic presentations on aortic disease diagnosis and treatment in more than 30 countries and regions. Has been invited to attend the American College of Surgeons Annual Meeting for four consecutive years and the Veith Symposium for five consecutive years as a Faculty Member, delivering keynote speeches. As Co-Chair of the conference, led the Chinese vascular surgery delegation to inaugurate a China-West dialogue session at the Cardiovascular Summit of the Royal College of Physicians in the UK. As the only Chinese expert, presented China's experience in endovascular treatment of aortic diseases at the opening plenary session of the 24th European Society for Vascular Surgery Annual Meeting. Represented China in the formulation of the TASC international guidelines for the diagnosis and treatment of peripheral vascular diseases.
出版者信息








《广州医药》公众号